New Results
Distal super-enhancer drives aberrant CXCL13 expression in Cancer cells driving growth and p53 dysregulation via CXCR5-CXCL13 axis
View ORCID ProfileSantosh Kumar Gothwal, View ORCID ProfilePieta K. Mattila, Jacqueline H Barlow
doi: https://doi.org/10.1101/2024.08.31.609994
Santosh Kumar Gothwal
1Institute of Frontier Science Initiative, Kanazawa University, Japan
2Central Research Resource Center, Cancer Research Institute, Kanazawa University,
Pieta K. Mattila
3Institute of Biomedicine and MediCity Research Laboratories, University of Turku, Turku, Finland
4InFLAMES Research Flagship, University of Turku, Turku, Finland
5Turku Bioscience, University of Turku and Åbo Akademi University, Turku, Finland
Jacqueline H Barlow
6Department of Microbiology and Molecular Genetics, University of California, Davis, United States
Article usage
Posted September 04, 2024.
Distal super-enhancer drives aberrant CXCL13 expression in Cancer cells driving growth and p53 dysregulation via CXCR5-CXCL13 axis
Santosh Kumar Gothwal, Pieta K. Mattila, Jacqueline H Barlow
bioRxiv 2024.08.31.609994; doi: https://doi.org/10.1101/2024.08.31.609994
Subject Area
Subject Areas
- Biochemistry (12953)
- Bioengineering (9845)
- Bioinformatics (31580)
- Biophysics (16279)
- Cancer Biology (13356)
- Cell Biology (19042)
- Clinical Trials (138)
- Developmental Biology (10317)
- Ecology (15330)
- Epidemiology (2067)
- Evolutionary Biology (19576)
- Genetics (12984)
- Genomics (17951)
- Immunology (13068)
- Microbiology (30539)
- Molecular Biology (12729)
- Neuroscience (66657)
- Paleontology (490)
- Pathology (2064)
- Pharmacology and Toxicology (3551)
- Physiology (5537)
- Plant Biology (11414)
- Synthetic Biology (3174)
- Systems Biology (7838)
- Zoology (1769)